What does Abscint do?
Abscint specializes in developing innovative solutions for the detection and quantification of biomolecules. The company focuses on providing advanced technologies for research and clinical applications in the fields of diagnostics and therapeutics. With a commitment to enhancing scientific understanding, Abscint aims to improve health outcomes through its products and services.
Juridical situation
Company number
Founding date
EUID number
Type of enterprise
Location
Juridical form
- Signals
-
ProfitableProfitable € 364K
The company reported a positive net result in the latest financial year.
Strong equityStrong equity € 5.56MStrong equity provides a buffer against setbacks.
Low riskLow risk 81.1%Good solvency (> 30%) points to long-term financial stability.
Good liquidityGood liquidity 3.89A healthy current ratio (≥ 1.5): enough current assets to cover short-term debt.
Positive cashflowPositive cashflow € 658KPositive operating cash flow in the latest financial year.
Positive EBITDAPositive EBITDA € 541KPositive EBITDA: operating activities are profitable.
Healthy social debtHealthy social debt 8.8%Social debts stay manageable relative to personnel costs.
- Shareholders
- Noshaq Spin-Offs 15,74%, Qbic Ii Fund Arkiv 13,96%
|
|
2025
|
2024
|
2023
|
2022
|
|---|---|---|---|---|
|
€
871K
|
€
-660K
|
€
-328K
|
€
-250K
|
|
|
€
541K
|
€
-1.04M
|
€
-622K
|
€
-434K
|
|
|
€
364K
|
€
-1.34M
|
€
-1.01M
|
€
-464K
|
|
|
€
5.56M
|
€
3.47M
|
€
4.48M
|
€
1.30M
|
|
|
81.14%
|
81.17%
|
94.57%
|
89.37%
|
|
|
€
1.29M
|
€
804K
|
€
258K
|
€
154K
|
|
|
€
2.78M
|
€
2.15M
|
€
2.99M
|
€
986K
|
|
|
3.00
|
3.00
|
2.00
|
2.00
|
Publications 8
All publications- Capital, Actions 05/02/2024
- Statuts (Traduction, Coordination, Autres Modifications, ) 06/10/2023
- Maatschappelijke Zetel - Kapitaal - Aandelen - Ontslagen - Benoemingen - Statuten (Vertaling, Cordinatie, Overige Wijzigingen, ) 03/10/2023
- Statuten (Vertaling, Cordinatie, Overige Wijzigingen, ) - Kapitaal - Aandelen - Ontslagen - Benoemingen 18/11/2022
- Statuten (Vertaling, Cordinatie, Overige Wijzigingen, ) - Kapitaal - Aandelen - Ontslagen - Benoemingen 28/05/2021
Frequently asked questions
Answers to the most common questions about Abscint, based on official government data and the filed annual accounts.
What is the VAT number of Abscint?
The VAT number of Abscint is BE0749.828.410.
How many employees work at Abscint?
In 2025, Abscint employed 3.00 full-time equivalents (FTE).
When was Abscint established?
Abscint was founded in 06-07-2020.
What is the official address of Abscint?
The official address of Abscint is Boulevard De Patience Et Beaujonc 3/23 Liège 4000.
What is the legal form of Abscint?
The juridical form of Abscint is Public limited company (NV/SA).
What is the legal situation of Abscint?
The legal situation of Abscint is Normal situation.
What is the annual revenue of Abscint?
The annual revenue of Abscint is €0.
What does Abscint do?
Abscint specializes in developing innovative solutions for the detection and quantification of biomolecules. The company focuses on providing advanced technologies for research and clinical applications in the fields of diagnostics and therapeutics. With a commitment to enhancing scientific understanding, Abscint aims to improve health outcomes through its products and services.
Where can I find Abscint?
Abscint is located at Boulevard De Patience Et Beaujonc 3/23 Liège 4000 in Liège (4000).
Is Abscint a reliable company?
Abscint is a registered Rechtspersoon with company number 0749.828.410 and can be verified through the official CBE database.
What is the credit limit of Abscint?
The estimated credit limit of Abscint is €798,595.
Is Abscint still active?
Abscint currently has the status "Normal situation" and is actief.